A research-grade dual-action GH secretagogue blend combining CJC-1295 No DAC (5MG) and Ipamorelin (5MG). The GHRH analogue and ghrelin mimetic act through complementary receptor pathways to amplify GH pulsatility in preclinical models.
| Blend Ratio | CJC-1295 5MG + Ipamorelin 5MG |
| CAS CJC-1295 | 863288-34-0 |
| CAS Ipamorelin | 170851-70-4 |
| Form | Lyophilized powder |
| Purity | ≥99% |
| Vial | 6ML sealed flip-top |